Journal Report

Current Pharmaceutical Analysis

Download PDF
Journal Information
Journal Title
Current Pharmaceutical Analysis
Publisher
KeAi Communications Co.
ISSN
1573-4129
E-ISSN
1875-676X
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Targeting the oncogenic SND1-MTDH interface through drugbank-based virtual screening: structural and electronic insights from molecular docking, molecular dynamics, and DFT analyses
Alaa H.M. Abdelrahman, Dina E.M. Mohamed, Peter A. Sidhom et al.
2026-11 Vol. 22 Issue 9 Pages 850-863
Potential cardioprotective mechanisms of Bawu Junzi decoction in myocardial infarction: Identification of CYP1B1 and ALDH2 as key mediators
Fengtong Li, Jingmei Chai
2026-11 Vol. 22 Issue 9 Pages 803-813
A comparative bibliometric analysis of natural product-based combination therapies in lung cancer: Insights into analytical strategies and translational challenges
Chuanlong Zhang, Mengqi Gao, Xiyuan Zhang et al.
2026-11 Vol. 22 Issue 9 Pages 833-849
Paeoniflorin alleviates sepsis-induced liver injury: Insights from integrative transcriptomic and metabolomic analysis
Li Li, Xinyu Gu, Hui Wang et al.
2026-11 Vol. 22 Issue 9 Pages 822-832
In vitro evidence of Piperlongumine as a potential radiosensitizer in cervical cancer cells
Li Shan, Ye Lu, Xiaoli Zhu et al.
2026-11 Vol. 22 Issue 9 Pages 814-821
Novel dichloroacetamide derivatives: Synthesis, cytotoxicity evaluation, molecular docking study, MD simulations, and ADME study
Amirhossein Abbassi, Leila Emami, Mahkameh Moradimehrabadi et al.
2026-10 Vol. 22 Issue 8 Pages 792-802
Network pharmacology and molecular docking reveal the active compounds and key targets of JiaWei SiNi San in hepatocellular carcinoma
Fan Zhang, Haojia Wu, Jing Wu et al.
2026-10 Vol. 22 Issue 8 Pages 781-791
5-Benzylacyclouridine suppresses malignant phenotypes and aerobic glycolysis in lung adenocarcinoma cells in association with reduced UPP1 expression
Jing Yu, Wei Zhang, Luqi Liu et al.
2026-10
Real-world adverse event signals of immunotherapeutic agents in lung cancer: A pharmacovigilance data mining approach
Jiahui Gao, Xu Lu, Feng Liu
2026-10 Vol. 22 Issue 8 Pages 724-733
Refining sedation strategies in elderly patients: A critical analysis of esketamine and propofol combination in gastrointestinal endoscopy
Muhammad Taufan Umasugi, Muhammad Azril Hardiman Mahulauw, Djulfikri Mewar
2026-10 Vol. 22 Issue 8 Pages 722-723
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 3, 2026 05:27